Skip to main content
TipRanks
Go Ultimate75% OFF

Sharp Therapeutics Corp. (SHRX) Ownership - Who Owns Sharp Therapeutics Corp.?

0 Followers

Sharp Therapeutics Corp. (SHRX) Ownership Overview

  • 22.25% Insiders
  • 77.75% Public Companies and Individual Investors

The ownership structure of Sharp Therapeutics Corp. (TSE:SHRX) stock is a mix of institutional, retail, and individual investors. , 22.25% is owned by Insiders, and 77.75% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 07, 2026William R NewlinC$280,001
Nov 03, 2025William R Newlin$7,105

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

TSE:SHRX top shareholders
Holder# of SharesType% HoldingValue
William R Newlin5,108,336Insider22.25%4,898,894

FAQ

What percentage of Sharp Therapeutics Corp. (TSE:SHRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 77.75% of Sharp Therapeutics Corp. (TSE:SHRX) stock is held by public companies and individual investors.
Who owns the most shares of Sharp Therapeutics Corp. (TSE:SHRX)?
William R Newlin owns the most shares of Sharp Therapeutics Corp. (TSE:SHRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.